The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked investment insights, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • News
  • Stocks
  • Energy
  • Tech
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • Inflation Capitulation Signals Dollar’s Demise, Gold’s Rise
  • Investors Forget About Gold At WORST Possible Time
  • Which Equities Can Best Survive Hyperinflation?
  • U.S. Hyperinflation Unmasked: BoA Sees ‘Transitory Hyper-inflation’ Coming
  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
Psychedelic Stocks
Exploring the companies and themes that make up this emerging and exciting new sector

COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults

2022-05-09 PSW Editor

Compass Pathways announces the first-ever study of psilocybin therapy on autistic adults, using COMP360.

New York Lawmakers Discuss Competing Psychedelics Reform Bills Ahead Of Key Deadline

2022-05-06 Noah Daly

With just a month left before the end of New York’s legislative session, lawmakers sponsoring differing psychedelics reform legislation recently participated in a discussion on the path forward for psilocybin in the Empire State.

PharmaTher Announces Grant of U.S. Patent on Formulation and Production Process of Ketamine and Ketamine Analogs

2022-05-05 PSW Editor

Pharmather announces receiving a patent from the USPTO for its "ketamine flow synthesis". Pharmather has exclusive worldwide development and commercial rights to this IP.

Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights

2022-05-04 PSW Editor

Wesana reports its Q4 2021 financial results and announces closing of a financing.

Optimi Health Granted Amendment To Controlled Substances Dealer’s Licence

2022-05-04 PSW Editor

Optimi Health announces receiving amendment to Health Canada's Dealer's License that will allow expand cultivation and research use of psilocybin and psilocin.

Awakn Life Sciences Reports Fiscal Fourth Quarter and Fiscal Year January 31, 2022, Results

2022-05-02 PSW Editor

Awakn Life Sciences reports fourth quarter and full-year results for its fiscal year ending January 31, 2022. Annual revenues of CAD$236,037.

Incannex Completes Loyalty Option Program to Raise A$23.6M; Current Cash at Bank is Approximately A$40.0M

2022-04-29 PSW Editor

Incannex Healthcare announces a "shareholder loyalty option" to raise A$23.6 million (US$16.5 million). For every two shares purchased, investors will receive a "piggyback option".

Optimi Health Opens Canada’s Largest GMP-Grade Licensed Psilocybin Cultivation Facility

2022-04-29 PSW Editor

Optimi Health announces the opening of Canada's largest GMP-grade psilocybin cultivation operating, including a 10,000 square foot production facility.

TRYP THERAPEUTICS DOSES FIRST PATIENT IN PHASE II PSILOCYBIN-ASSISTED THERAPY CLINICAL TRIAL

2022-04-28 PSW Editor

Tryp Therapeutics announces initial patient enrollment in its Phase II clinical trial of a psilocybin-based compound (TRP-8802) for Binge Eating Disorder.

Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies

2022-04-28 PSW Editor

Field Trip announces its corporate decision to separate Field Trip Health and Field Trip Discovery into separate companies.

Is The Psychedelic Drug Industry Entering A New Phase?

2022-04-28 Jeff Nielson

Several major new deals in the psychedelics industry already in 2022 suggest that the industry could be moving on to its next phase of evolution.

Is Minera Alamos Revolutionizing Gold Mining For The 21st Century?

2022-04-27 Jeff Nielson

Minera Alamos' "new" model for successful gold mining in the 21st century has a very retro flair to it.

  • Previous
  • 1
  • ...
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • ...
  • 73
  • Next
Join our Newsletter
 Hand-picked investment insights, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

A New Opportunity in Graphene?

A New Opportunity in Graphene?

2023-07-26
Is Blue Water Petroleum Corp going to be the tech company that finally launches large-scale graphene commercialization?

Inflation Capitulation Signals Dollar’s Demise, Gold’s Rise

Investors Forget About Gold At WORST Possible Time

Which Equities Can Best Survive Hyperinflation?

U.S. Hyperinflation Unmasked: BoA Sees ‘Transitory Hyper-inflation’ Coming

Psychedelic Stocks
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2025, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor